Recordati Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Corregio Italy (1926)

Organization Overview

First Clinical Trial
2006
NCT00359905
First Marketed Drug
1943
methamphetamine (desoxyn)
First NDA Approval
1957
ethotoin (peganone)
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Casen Recordati S.L. | Laboratoires Bouchara-Recordati | Recordati Industria Chimica e Farmaceutica S.p.A. | RECORDATI RARE | Recordati Rare Diseases